Advertisement
Advertisement
ATRA
Atara Biotherapeutics, Inc
8.81
USDSponsored
+0.27
+3.16%
Sep 25, 15:59 UTC -4
Closed
After-Market
8.81
0.00
+0.06%
Atara Biotherapeutics, Inc Financial Snapshot
| Market Cap | 88.48M |
| Beta | 0.10 |
| Earnings Per Share (EPS) | -1.18 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -269.42% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -79.12% |
| Current Ratio | 1.98% |
| Free Cash Flow | -6.41M |
